ERBB2 and ovarian mucinous adenocarcinoma: Taking into account that high overexpression of EpCAM is observed in 85% of mucinous ovarian carcinomas and in 90% of ovarian clear cell carcinomas [70], there must be tumors of these histotypes with high levels of both HER2 and EpCAM expression.